Chuck Royce's ANIP Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 24,051 shares of ANI Pharmaceuticals, Inc. (ANIP) worth $1.85 M, representing 0.02% of the portfolio. First purchased in 2018-Q3, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in ANIP, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 24,051 shares. Largest reduction occurred in Q3 2020, reducing 1,036 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's ANI Pharmaceuticals (ANIP) Holding Value Over Time
Track share changes against reported price movement
Quarterly ANI Pharmaceuticals (ANIP) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +24,051 | New Buy | 24,051 | $76.90 |
| Q3 2020 | -1,036 | Sold Out | 0 | $0.00 |
| Q2 2020 | +333 | Add 47.37% | 1,036 | $32.82 |
| Q1 2020 | +144 | Add 25.76% | 703 | $41.25 |
| Q4 2019 | +44 | Add 8.54% | 559 | $60.82 |
| Q3 2019 | +183 | Add 55.12% | 515 | $73.79 |
| Q2 2019 | -62 | Reduce 15.74% | 332 | $81.33 |
| Q1 2019 | +48 | Add 13.87% | 394 | $71.07 |
| Q4 2018 | -58 | Reduce 14.36% | 346 | $46.24 |
| Q3 2018 | +404 | New Buy | 404 | $56.93 |
Chuck Royce's ANI Pharmaceuticals Investment FAQs
Chuck Royce first purchased ANI Pharmaceuticals, Inc. (ANIP) in Q3 2018, acquiring 404 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held ANI Pharmaceuticals, Inc. (ANIP) for 10 quarters since Q3 2018.
Chuck Royce's largest addition to ANI Pharmaceuticals, Inc. (ANIP) was in Q1 2026, adding 24,051 shares worth $1.85 M.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 24,051 shares of ANI Pharmaceuticals, Inc. (ANIP), valued at approximately $1.85 M.
As of the Q1 2026 filing, ANI Pharmaceuticals, Inc. (ANIP) represents approximately 0.02% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in ANI Pharmaceuticals, Inc. (ANIP) was 24,051 shares, as reported at the end of Q1 2026.